These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2494933)

  • 1. Immunity to Brucella abortus induced in mice by popliteal lymph node restricted strain 19 vaccination.
    Plommet M; Plommet AM
    Ann Rech Vet; 1989; 20(1):73-81. PubMed ID: 2494933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell-wall fraction.
    Plommet M; Plommet AM
    Ann Rech Vet; 1987; 18(4):429-37. PubMed ID: 3451687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serologic responses, lymphocyte proliferative responses, and clearance from lymphatic organs after vaccination of bison with Brucella abortus strain RB51.
    Olsen SC; Jensen AE; Palmer MV; Stevens MG
    Am J Vet Res; 1998 Apr; 59(4):410-5. PubMed ID: 9563622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-Brucella immunity transferred by immune serum and that transferred by splenic lymphocytes cannot be added].
    Plommet M; Hue I; Plommet AM
    Ann Rech Vet; 1986; 17(2):169-75. PubMed ID: 3096188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
    Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
    Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(4):245-51. PubMed ID: 3148291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
    Muñoz PM; de Miguel MJ; Grilló MJ; Marín CM; Barberán M; Blasco JM
    Vaccine; 2008 May; 26(21):2562-9. PubMed ID: 18423950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine and serum-mediated protection against brucella infection of mouse placenta.
    Bosseray N
    Br J Exp Pathol; 1983 Dec; 64(6):617-25. PubMed ID: 6419766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
    Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
    J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice.
    Bosseray N
    Br J Exp Pathol; 1978 Aug; 59(4):354-65. PubMed ID: 101226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Adone R
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):43-55. PubMed ID: 16112746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.
    Pardon P
    Ann Immunol (Paris); 1977; 128(6):1025-37. PubMed ID: 413471
    [No Abstract]   [Full Text] [Related]  

  • 16. Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.
    Bosseray N; Plommet M
    Vaccine; 1990 Oct; 8(5):462-8. PubMed ID: 2123586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godfroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Oct; 69(10):6264-70. PubMed ID: 11553569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S; Cannat A; Huguet MF; Serre A
    Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine.
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Fosgate GT
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):209-20. PubMed ID: 15963819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.